twitter Tweet

OHSU Brain Institute hosts annual Brain Awareness Season lecture series

OHSU neuroscientists, physicians discuss long COVID, Alzheimer’s prevention and psilocybin
OHSU Brain Awareness 2023


CALENDAR ALERT

WHAT: 
The OHSU Brain Institute at Oregon Health & Science University will host its annual Brain Awareness Lecture Series virtually again this year, starting with the first presentation on Monday, April 3, and again on April 10 and April 17. The annual event, which started in 2000, is one of the largest of its kind in the United States, drawing thousands of participants to share information and learn about the brain.

In addition, the OHSU Brain Institute will host its annual Brain Fair from 10 a.m. to 4 p.m. this Saturday, March 11, at the Oregon Museum of Science and Industry (OMSI) in Portland.

LECTURE DETAILS: 
Noon, April 3: Mental health and long COVID: A neuropsychiatry perspective

Jordan Anderson, D.O. (OHSU)
Jordan Anderson, D.O. (OHSU)

Jordan Anderson, D.O., director of the OHSU Long COVID Neuropsychiatry Clinic, will outline what we know about how the virus affects cognition and mental health in the long term, and provide tips and strategies for ongoing management of the disease. In March of 2021, OHSU established one of the first long COVID clinics in the country to treat the disease, defined as patients experiencing symptoms more than four weeks after the acute infection.

Register to receive the live-stream link.

 

Noon, April 10: Is prevention of Alzheimer’s disease possible?

Aimee Pierce, M.D. (OHSU)
Aimee Pierce, M.D. (OHSU)

Aimee Pierce, M.D., associate professor of neurology in the OHSU School of Medicine, will discuss novel clinical trials involving a newly approved medication called lecanemab to slow the progression of symptoms early or even before patients experience any cognitive impairment at all. Pierce, director of clinical care and therapeutics in the OHSU Layton Aging and Alzheimer’s Disease Center, also will discuss lifestyle interventions to reduce the risk of the disease, including diet, exercise and sleep.

Register to receive the live-stream link.

 

Noon, April 17: Psilocybin and Oregon: What to expect in 2023 and beyond

Atheir Abbas, M.D., Ph.D. (OHSU)
Atheir Abbas, M.D., Ph.D. (OHSU)

Atheir Abbas, M.D., Ph.D., assistant professor of behavioral neuroscience and psychiatry in the OHSU School of Medicine, will provide an overview of psilocybin, how it can be used, how we got to where we are in Oregon as the first U.S. state to approve a legal framework for providing psilocybin services to the general public, and what to expect in the new year. Abbas served as a member of the Oregon Psilocybin Advisory Board.

Register to receive the live-stream link.

Previous Story Gene editing research highlighted in November OHSU Science Café series Next Story National Poison Prevention Week reminder: Poisonings are preventable
Facebook Twitter LinkedIn YouTube Instagram OHSU Braille services OHSU sign language services OHSU interpreter services